Unidad de Investigacion Medica en Enfermedades Renales

1 marketed ·

Quick facts

Marketed products

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Unidad de Investigacion Medica en Enfermedades Renales

What are Unidad de Investigacion Medica en Enfermedades Renales's marketed drugs?

Top marketed products include ESW group.

Related